The new pill for overactive bladder (OAB) is GEMTESA (vibegron). This oral medication is specifically indicated for the treatment of overactive bladder in adults who experience symptoms such as urge urinary incontinence (UUI), urgency, and urinary frequency.
Understanding GEMTESA (vibegron)
GEMTESA (vibegron) is designed to help manage the disruptive symptoms associated with OAB. It is an oral, once-daily tablet, making it a convenient option for adults seeking relief from their bladder issues.
Key Features of GEMTESA (vibegron)
| Feature | Detail |
|---|---|
| Pill Name | GEMTESA (vibegron) |
| Formulation | Oral, film-coated tablet |
| Dosage | 75mg strength, taken once daily |
| Appearance | Oval, light green tablet |
| Indication | Treatment of Overactive Bladder (OAB) with symptoms of urge urinary incontinence (UUI), urgency, and urinary frequency |
| Target Group | Adults |
How GEMTESA Addresses OAB Symptoms
Overactive bladder is characterized by a sudden, compelling urge to urinate that is difficult to defer, often leading to involuntary leakage (urge urinary incontinence), and frequent urination throughout the day and night. GEMTESA (vibegron) works to alleviate these specific symptoms, aiming to improve bladder control and reduce the frequency and urgency of urination.
As a once-daily oral medication, GEMTESA (vibegron) offers a straightforward approach to managing the persistent challenges of OAB.
